How Vasoactive Intestinal Peptide May Treat Ulcerative Colitis Through Immune Regulation
VIP regulates IL-10 expression in regulatory B cells, offering a potential new therapeutic strategy for ulcerative colitis by modulating gut immune responses.
Quick Facts
What This Study Found
VIP regulates IL-10 expression in regulatory B cells, influencing the Th1/Th2 balance and potentially providing a new mechanism for treating ulcerative colitis.
Key Numbers
Proposed pathway: VIP → Bregs → IL-10 → Th2 shift; Bregs produce IL-10, IL-35, TGF-β
How They Did This
Narrative review of published literature on VIP immunomodulation and regulatory B cell biology in colitis.
Why This Research Matters
Ulcerative colitis has increasing global incidence with limited treatment options. VIP's ability to modulate gut immunity through regulatory B cells could lead to novel, targeted therapies.
The Bigger Picture
Understanding the neuro-immune axis in the gut — how neuropeptides like VIP influence immune cells — could unlock new treatment approaches for inflammatory bowel disease.
What This Study Doesn't Tell Us
Review of an evolving field. The exact mechanisms of VIP-Breg-IL-10 interaction are still being clarified.
Questions This Raises
- ?Could exogenous VIP administration treat UC in clinical trials?
- ?What is the optimal route for delivering VIP to the gut?
- ?Are VIP levels altered in UC patients compared to healthy individuals?
Trust & Context
- Key Stat:
- Neuro-immune axis VIP connects the enteric nervous system to immune regulation through regulatory B cell IL-10 production
- Evidence Grade:
- Review article synthesizing animal and human experimental data. Promising mechanistic basis but clinical application remains theoretical.
- Study Age:
- Published in 2020. VIP-based immunomodulation for IBD continues to be researched.
- Original Title:
- Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells.
- Published In:
- World journal of gastroenterology, 26(48), 7593-7602 (2020)
- Authors:
- Sun, Xiong, Huang, Yao, Zhang, Ya-Li, Qiao, Dan, Dai, Yan-Cheng
- Database ID:
- RPEP-05152
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is VIP and what does it do in the gut?
Vasoactive intestinal peptide is a neuropeptide produced by nerve cells in the gut. It acts as an anti-inflammatory signal, helping regulate immune responses in the intestinal lining to prevent excessive inflammation.
How could VIP help treat ulcerative colitis?
VIP promotes the production of IL-10, an anti-inflammatory molecule, by regulatory B cells. This helps balance the immune system and suppress the overactive inflammation that drives UC symptoms.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05152APA
Sun, Xiong; Huang, Yao; Zhang, Ya-Li; Qiao, Dan; Dai, Yan-Cheng. (2020). Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells.. World journal of gastroenterology, 26(48), 7593-7602. https://doi.org/10.3748/wjg.v26.i48.7593
MLA
Sun, Xiong, et al. "Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells.." World journal of gastroenterology, 2020. https://doi.org/10.3748/wjg.v26.i48.7593
RethinkPeptides
RethinkPeptides Research Database. "Research advances of vasoactive intestinal peptide in the pa..." RPEP-05152. Retrieved from https://rethinkpeptides.com/research/sun-2020-research-advances-of-vasoactive
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.